Search Results 1091-1100 of 18353 for Hepatitis C

1. Cholangiocarcinoma (bile duct cancer) - Symptoms and causes - Mayo Clinic

   Lavu S, et al. Effect of statins on the risk of extrahepatic cholangiocarcinoma. 2020; doi:10.1002/hep.31146. Rea DJ, et al. Liver transplantation with ...

2. A Study to Evaluate IONIS-TMPRSS6-LRx (ISIS 702843) in Patients with Polycythemia Vera - Mayo Clinic

   Active infection with human immunodeficiency virus (HIV), hepatitis C, or hepatitis B. 6. Active infection requiring systemic antiviral or antimicrobial ...

3. Publications - Melanie D. Swift, M.D., M.P.H. - Mayo Clinic

   Minter S, Hainy C, Swift M, Yee C, Meyers J, Nos A, Breeher L. Quality Assessment of a Virtual Post Offer Placement Assessment in Employee Occupational Health ...

4. Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas - Mayo Clinic

   Negative Hepatitis B and Hepatitis C testing;; QTc interval ≤450ms. Exclusion Criteria: Radiation within 14 days of study entry, thoracic radiation within ...

5. Evaluating the Safety, Tolerability and Effectiveness of ADX-629 t to Treat Chronic Cough - Mayo Clinic

   - Positive serology test for Hepatitis B virus (HBV), Hepatitis C virus (HCV), or HIV-1 and HIV-2 - Currently taking an angiotensin converting enzyme ...

6. Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma - Mayo Clinic

   hepatitis B surface antigen or hepatitis C antibody - No history of any other condition that may require the initiation of anti-tumor necrosis factor alpha ...

7. A Study Of The Pan-KRAS Inhibitor LY4066434 In Participants With KRAS Mutant Solid Tumors - Mayo Clinic

   * Have known active hepatitis B virus (HBV), hepatitis C virus (HCV) and untreated HIV infection * Have other active malignancy unless in remission with ...

8. A Study of Atezolizumab Alone or Combined with Immunomodulatory Drug and/or Daratumumab in Multiple Myeloma Patients - Mayo Clinic

   Active hepatitis B, active hepatitis C, or positive for human immunodeficiency virus (HIV). Uncontrolled, clinically significant pulmonary disease (for ...

9. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

   Known active hepatitis B or hepatitis C: Patients with a positive hepatitis B core antibody but with negative hepatitis B DNA may participate, but must have ...

10. A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer - Mayo Clinic

    Active hepatitis B or hepatitis C. Severe infection at the time of randomization. Treatment with any other investigational agent with therapeutic intent ...